{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:50:17Z","timestamp":1793332217194,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013948","name":"Tempus K\u00f6zalap\u00edtv\u00e1ny","doi-asserted-by":"publisher","award":["E\u00f6tv\u00f6s Scholarship"],"award-info":[{"award-number":["E\u00f6tv\u00f6s Scholarship"]}],"id":[{"id":"10.13039\/501100013948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40123-024-00924-z","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T15:02:01Z","timestamp":1710946921000},"page":"1343-1356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-9442","authenticated-orcid":false,"given":"G\u00e1bor","family":"T\u00f3th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luk\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Stachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schirra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor L\u00e1szl\u00f3","family":"S\u00e1ndor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra","family":"Szentm\u00e1ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.survophthal.2016.01.004","volume":"61","author":"R Jain","year":"2016","unstructured":"Jain R, Sharma N, Basu S, et al. Stevens-Johnson syndrome: the role of an ophthalmologist. Surv Ophthalmol. 2016;61:369\u201399.","journal-title":"Surv Ophthalmol"},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s40123-023-00725-w","volume":"12","author":"G T\u00f3th","year":"2023","unstructured":"T\u00f3th G, Luk\u00e1cs A, Schirra F, et al. Ophthalmic aspects of Stevens-Johnson ayndrome and toxic epidermal necrolysis: a narrative review. Ophthalmol Ther. 2023;12:1795\u2013811.","journal-title":"Ophthalmol Ther"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"20275","DOI":"10.1038\/s41598-021-99370-1","volume":"11","author":"R Panpruk","year":"2021","unstructured":"Panpruk R, Puangsricharern V, Klaewsongkram J, et al. Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis. Sci Rep. 2021;11:20275.","journal-title":"Sci Rep"},{"key":"924_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00347-021-01351-2","volume":"118","author":"A Chronopoulos","year":"2021","unstructured":"Chronopoulos A, Mockenhaupt M, Pleyer U. Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ophthalmologe. 2021;118:519\u201332.","journal-title":"Ophthalmologe"},{"key":"924_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0378-6323.110749","volume":"79","author":"TK Patel","year":"2013","unstructured":"Patel TK, Barvaliya MJ, Sharma D, Tripathi C. A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Indian J Dermatol Venereol Leprol. 2013;79:389\u201398.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12886-017-0464-9","volume":"17","author":"LLW Chow","year":"2017","unstructured":"Chow LLW, Shih KC, Chan JCY, Lai JSM, Ng ALK. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study. BMC Ophthalmol. 2017;17:65.","journal-title":"BMC Ophthalmol"},{"key":"924_CR7","doi-asserted-by":"publisher","first-page":"2087578","DOI":"10.1155\/2017\/2087578","volume":"2017","author":"P Jongkhajornpong","year":"2017","unstructured":"Jongkhajornpong P, Lekhanont K, Siriyotha S, Kanokrungsee S, Chuckpaiwong V. Factors contributing to long-term severe visual impairment in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Ophthalmol. 2017;2017:2087578.","journal-title":"J Ophthalmol"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3341\/kjo.2020.0118","volume":"35","author":"S Ganekal","year":"2021","unstructured":"Ganekal S, Nagarajappa A. Acute and chronic ophthalmic involvement, severity, and sequelae in Stevens-Johnson syndrome and toxic epidermal necrolysis. Korean J Ophthalmol. 2021;35:179\u201387.","journal-title":"Korean J Ophthalmol"},{"key":"924_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10792-017-0576-5","volume":"38","author":"LLW Chow","year":"2018","unstructured":"Chow LLW, Ng ALK, Chow SSW, et al. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Int Ophthalmol. 2018;38:1155\u201360.","journal-title":"Int Ophthalmol"},{"key":"924_CR10","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/ICO.0000000000002263","volume":"39","author":"Y Yoshikawa","year":"2020","unstructured":"Yoshikawa Y, Ueta M, Fukuoka H, et al. Long-term progression of ocular surface disease in Stevens-Johnson syndrome and toxic epidermal necrolysis. Cornea. 2020;39:745\u201353.","journal-title":"Cornea"},{"key":"924_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.644795","volume":"8","author":"S Jabbour","year":"2021","unstructured":"Jabbour S, Din N, Logeswaran A, Sanchez ST, Ahmad S. Clinical characteristics of patients with chronic Stevens-Johnson syndrome treated at a major tertiary eye hospital within the United Kingdom. Front Med. 2021;8: 644795.","journal-title":"Front Med"},{"key":"924_CR12","first-page":"283","volume":"50","author":"VB Kompella","year":"2002","unstructured":"Kompella VB, Sangwan VS, Bansal AK, Garg P, Aasuri MK, Rao GN. Ophthalmic complications and management of Stevens-Johnson syndrome at a tertiary eye care centre in South India. Indian J Ophthalmol. 2002;50:283\u20136.","journal-title":"Indian J Ophthalmol"},{"key":"924_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"c91","author":"MV De Rojas","year":"2007","unstructured":"De Rojas MV, Dart JKG, Saw VPJ. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol. 2007;c91:1048\u201353.","journal-title":"Br J Ophthalmol"},{"key":"924_CR14","first-page":"157","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry J, Roujeau J-C, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145:157\u201362.","journal-title":"Arch Dermatol"},{"key":"924_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","volume":"35","author":"R Rajaratnam","year":"2010","unstructured":"Rajaratnam R, Mann C, Balasubramaniam P, et al. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clin Expert Dermatol. 2010;35:853\u201362.","journal-title":"Clin Expert Dermatol"},{"key":"924_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jtos.2021.04.009","volume":"21","author":"R Rashad","year":"2021","unstructured":"Rashad R, Shanbhag SS, Kwan J, Chodosh J, Saeed S, Saeed HN. Chronic ocular complications in lamotrigine vs. trimethoprim-sulfamethoxazole induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Ocul Surf. 2021;21:16\u20138.","journal-title":"Ocul Surf"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-018-0185-z","volume":"13","author":"H Schurz","year":"2019","unstructured":"Schurz H, Salie M, Tromp G, Hoal E, Kinnear CJ, M\u00f6ller M. The X chromosome and sex- specific effects in infectious disease susceptibility. Hum Genomics. 2019;13:2.","journal-title":"Hum Genomics"},{"key":"924_CR18","volume":"12","author":"F Angum","year":"2020","unstructured":"Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12:e8094.","journal-title":"Cureus"},{"key":"924_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","volume":"45","author":"J Kurko","year":"2013","unstructured":"Kurko J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. Genetics of rheumatoid arthritis\u2014a comprehensive review. Clin Rew Allergy Immunol. 2013;45:170\u20139.","journal-title":"Clin Rew Allergy Immunol"},{"key":"924_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2013.01.008","volume":"41","author":"Y Cui","year":"2013","unstructured":"Cui Y, Sheng Y, Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun. 2013;41:25\u201333.","journal-title":"J Autoimmun"},{"key":"924_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jdin.2022.12.002","volume":"11","author":"N Ubukata","year":"2022","unstructured":"Ubukata N, Nakatani E, Hashizume H, Sasaki H, Miyachi Y. Risk factors and drugs that trigger the onset of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database. JAAD Int. 2022;11:24\u201332.","journal-title":"JAAD Int"},{"key":"924_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/medicina57090895","volume":"57","author":"R Frantz","year":"2021","unstructured":"Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management. Medicina. 2021;57:895.","journal-title":"Medicina"},{"key":"924_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.643955","volume":"8","author":"SS Shanbhag","year":"2021","unstructured":"Shanbhag SS, Sangwan VS, Singh A, et al. Clinical aspects of Stevens-Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications in India. Front Med (Lausanne). 2021;8:643955.","journal-title":"Front Med (Lausanne)"},{"key":"924_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.644871","volume":"8","author":"T Imatoh","year":"2021","unstructured":"Imatoh T, Saito Y. Associations between Stevens-Johnson syndrome and infection: overview of pharmacoepidemiological studies. Front Med (Lausanne). 2021;8:644871.","journal-title":"Front Med (Lausanne)"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12876-022-02130-2","volume":"22","author":"X Xie","year":"2022","unstructured":"Xie X, Ren K, Zhou Z, Dang C, Zhang H. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 2022;22:58.","journal-title":"BMC Gastroenterol"},{"key":"924_CR26","first-page":"17","volume":"50","author":"J James","year":"2005","unstructured":"James J, Sushma M, Guido S, Elizabeth J. Cutaneous adverse drug reactions in a South Indian tertiary care center. Indian J Dermatol. 2005;50:17\u201321.","journal-title":"Indian J Dermatol"},{"key":"924_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7:803\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"924_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jtos.2020.03.004","volume":"18","author":"SS Shanbhag","year":"2020","unstructured":"Shanbhag SS, Hall L, Chodosh J, Saeed HN. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis. Ocul Surf. 2020;18:517\u201322.","journal-title":"Ocul Surf"},{"key":"924_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono C, Ang LPK, Koizumi N, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology. 2007;114:1294\u2013302.","journal-title":"Ophthalmology"},{"key":"924_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajo.2018.01.028","volume":"189","author":"S Basu","year":"2018","unstructured":"Basu S, Shanbhag SS, Gokani A, Kedar R, Bahuguna C, Sangwan VS. Chronic ocular sequelae of Stevens-Johnson syndrome in children: long-term impact of appropriate therapy on natural history of disease. Am J Ophthalmol. 2018;189:17\u201328.","journal-title":"Am J Ophthalmol"},{"key":"924_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/ICO.0000000000000680","volume":"35","author":"G Iyer","year":"2016","unstructured":"Iyer G, Srinivasan B, Agrawal S, Pillai VS, Ahuja A. Treatment modalities and clinical outcomes in ocular sequelae of Stevens-Johnson syndrome over 25\u00a0years\u2014a paradigm shift. Cornea. 2016;35:46\u201350.","journal-title":"Cornea"},{"key":"924_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/08820538.2015.1114841","volume":"31","author":"VS Chang","year":"2016","unstructured":"Chang VS, Chodosh J, Papaliodis GN. Chronic ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: the role of systemic immunomodulatory therapy. Semin Ophthalmol. 2016;31:178\u201387.","journal-title":"Semin Ophthalmol"},{"key":"924_CR33","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/ICU.0000000000000312","volume":"27","author":"HN Saeed","year":"2016","unstructured":"Saeed HN, Chodosh J. Ocular manifestations of Stevens-Johnson syndrome and their management. Curr Opin Ophthalmol. 2016;27:522\u20139.","journal-title":"Curr Opin Ophthalmol"},{"key":"924_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jtos.2021.03.011","volume":"21","author":"S Sing","year":"2021","unstructured":"Sing S, Jakati S, Shanbhag SS, Elhusseiny AM, Djalilian AR, Basu S. Lid margin keratinization in Stevens-Johnson syndrome: review of pathophysiology and histopathology. Ocul Surf. 2021;21:299\u2013305.","journal-title":"Ocul Surf"},{"key":"924_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ophtha.2016.04.041","volume":"123","author":"DG Gregory","year":"2016","unstructured":"Gregory DG. New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome. Ophthalmology. 2016;123:1653\u20138.","journal-title":"Ophthalmology"},{"key":"924_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajo.2019.01.028","volume":"203","author":"N Sharma","year":"2019","unstructured":"Sharma N, Venugopal R, Maharana PK, et al. Multistep grading system for evaluation of chronic ocular sequelae in patients with Stevens-Johnson syndrome. Am J Ophthalmol. 2019;203:69\u201377.","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00924-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-00924-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-00924-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T18:54:44Z","timestamp":1713898484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-00924-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-00924-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work of G\u00e1bor T\u00f3th at the Dr. Rolf M. Schwiete Center has been supported by the E\u00f6tv\u00f6s Scholarship and the work of N\u00f3ra Szentm\u00e1ry and Tanja Stachon at the Dr. Rolf M. Schwiete Center has been supported by the Dr. Rolf M. Schwiete Foundation. N\u00f3ra Szentm\u00e1ry is an Editorial Board member of <i>Ophthalmology and Therapy<\/i> and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. G\u00e1bor T\u00f3th, Andrea Luk\u00e1cs, Tanja Stachon, Frank Schirra, G\u00e1bor L\u00e1szl\u00f3 S\u00e1ndor, Zolt\u00e1n Zsolt Nagy and N\u00f3ra Szentm\u00e1ry have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Regional and Institutional Committee of Science and Research Ethics of Semmelweis University, Hungary (Number 242\/2020). The study was performed in accordance with the Declaration of Helsinki Guidelines for Human Research and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}